Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study.
Saved in:
| Title: | Disease-modifying therapies, outcomes, risk factors and severity of COVID-19 in multiple sclerosis: A MENACTRIMS registry based study. |
|---|---|
| Authors: | Zeineddine M; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France; School of Pharmacy, Lebanese American University, Byblos, Lebanon., Al-Hajje A; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon., Salameh P; Faculty of Pharmacy, Lebanese University, Beirut, Lebanon; National Institute of Public Health, Clinical Epidemiology and Toxicology (INSPECT-LB), Beirut, Lebanon; School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Primary Care and Population Health, University of Nicosia Medical School, 2417, Nicosia, Cyprus., Massouh J; Harley Street Medical Centre, Neurology Institute, Abu Dhabi, United Arab Emirates., Saab G; American University of Beirut Medical Center, Nehme and Therese Tohme Multiple Sclerosis Center, Beirut, Lebanon., Al-Roughani R; Amiri Hospital, Kuwait, Kuwait., Ahmed SF; Ibn Sina Hospital, Kuwait, Kuwait., Al-Mahdawi A; Baghdad Medical City Teaching Hospital, Baghdad, Iraq., Shalaby N; Neurology Department, Cairo University, Kasr Alainy School of Medicine, Cairo, Egypt., Inshasi J; MS Department, Rashid Hospital and Dubai Medical College, Dubai Health Authority, Dubai, United Arab Emirates., Sahraian MA; Multiple Sclerosis Research Center of Tehran University of Medical Sciences, Tehran, Iran., Gouider R; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health'- Razi University Hospital- Mannouba, Tunis, Tunisia., Mrabet S; Department of Neurology, LR18SP03, Clinical Investigation Center 'Neurosciences and Mental Health'- Razi University Hospital- Mannouba, Tunis, Tunisia., Al-Khabouri J; Department of Neurology, The Royal Hospital, Muscat, Oman., Shayganneja V; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran., Chentouf A; Neurology Department, University Hospital Center, Oran, Algeria., Boumediene F; Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, Omega Health, Limoges, France., Yamout B; Harley Street Medical Centre, Neurology Institute, Abu Dhabi, United Arab Emirates. Electronic address: yamoutba@gmail.com. |
| Source: | Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Oct; Vol. 90, pp. 105790. Date of Electronic Publication: 2024 Jul 28. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
